1. Avoiding immortal time bias in observational studies. Issue 3 (19th March 2020) Authors: Raymakers, Adam J.N.; Sadatsafavi, Mohsen; Sin, Don D.; FitzGerald, J. Mark; Marra, Carlo A.; Lynd, Larry D. Journal: European respiratory journal Issue: Volume 55:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review. Issue 1 (19th October 2016) Authors: Raymakers, Adam J.N.; McCormick, Natalie; Marra, Carlo A.; Fitzgerald, J. Mark; Sin, Don; Lynd, Larry D. Journal: Respirology Issue: Volume 22:Issue 1(2017) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Experiences and perspectives of individuals accessing CAR-T cell therapy: A qualitative analysis of online Reddit discussions. (December 2021) Authors: Jenei, Kristina; Burgess, Michael; Peacock, Stuart; Raymakers, Adam J.N. Journal: Journal of cancer policy Issue: Volume 30(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health-related quality of life data collected in chimeric antigen receptor T-cell (CAR-T) therapy clinical trials. (December 2021) Authors: Raymakers, Adam J.N.; Regier, Dean A.; Peacock, Stuart J.; Freeman, Ciara L. Journal: Journal of cancer policy Issue: Volume 30(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study. Issue 6 (6th June 2019) Authors: Raymakers, Adam J.N.; Sadatsafavi, Mohsen; Sin, Don D.; FitzGerald, J. Mark; Marra, Carlo A.; Lynd, Larry D. Journal: European respiratory journal Issue: Volume 53:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel. Issue 2 (June 2019) Authors: Raymakers, Adam J.N.; Regier, Dean A.; Peacock, Stuart J. Journal: Health policy and technology Issue: Volume 8:Issue 2(2019) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗